DSD-C124
Other / unspecified DSD · 46,XY · DSD-C124
Androgen resistance syndrome — partial male pseudohermaphroditism due to a qualitative androgen receptor defect. This case is unique in showing a marked response to high-dose androgen therapy (overcoming receptor dysfunction).
Images · 2
Case fields and evidence
- Category
-
Other / unspecified DSD
- Age
-
Infancy at initial presentation → followed up to 4 years
- Sex
-
Assigned female at birth, switched to male rearing at 5 days (testes palpable within labioscrotal folds)
- Karyotype
-
46,XY
- Genetics
-
AR
- Phenotypes
-
Micropenis (HP:0000054); Hypospadias (HP:0000047)
- Diagnosis
-
Androgen resistance syndrome — partial male pseudohermaphroditism due to a qualitative androgen receptor defect. This case is unique in showing a marked response to high-dose androgen therapy (overcoming receptor dysfunction).
- Follow-up
-
At 4 years, height 101 cm (50th percentile). Close monitoring of pubertal virilization.
- General phenotype
-
Generally normal apart from genitalia; after high-dose testosterone, sparse limb and upper-lip hair, mild axillary hyperpigmentation, and slight breast enlargement appeared (resolved within 3 months of discontinuation).
- Imaging
-
No imaging abnormality reported.
- Laboratory findings
-
Testosterone pre-hCG: 0.5 nmol/L (reference: low; time point: infancy); testosterone post-hCG: 5.1 nmol/L (reference: normal for age; time point: infancy, hCG 1000 U/d ×3 d); DHT (post-hCG): 0.89 nmol/L (reference: normal; time point: post-hCG); AR binding capacity (monolayer): 24.1 fmol/mg protein (reference: normal 15–30; time point: fibroblast culture); temperature sensitivity (30→41°C): binding decreased by 60% (reference: controls <20%; time point: key diagnostic indicator); ligand dissociation rate: accelerated 5-fold (reference: normal 50% requires 4–5 h vs proband 50 min; time point: key diagnostic indicator)
- Management
-
At 12 months, low-dose testosterone (50 mg q4w ×2) was ineffective → female rearing recommended. At 2.5 and 3.5 years, high-dose testosterone cypionate (100 mg q2w ×6 per course) for 2 courses yielded marked penile growth. At 4 years, left orchidopexy was performed, and in July 1988 a successful single-stage hypospadias repair.
- Pathology
-
Gonadal biopsy pathology not reported (testes palpable and functional).
- Evidence level
-
See source
- Clinical history
-
See source
- Perinatal history
-
See source
- Family history
-
See source
- Growth and development
-
See source
- External genital examination
-
See source
- Puberty / Tanner
-
See source
Cite this resource
DSD Research Library | Other / unspecified DSD · 46,XY · DSD-C124 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-C124?version=v1.4.0